Offer - Urjas Oil for just ₹ 1 X
Glynase 5 Tablet is a prescription drug, available for use as Tablet. Diabetes Type 2 are some of its major therapeutic uses. The alternative uses of Glynase 5 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Glynase 5 Tablet. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Glynase 5 Tablet as well, which are listed below. These side effects of Glynase 5 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Glynase 5 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Glynase 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Liver Disease, Heart Disease, Kidney Disease must refrain from the use of Glynase 5 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Glynase 5 Tablet contraindications section.
Drug interactions for Glynase 5 Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Glynase 5 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Glynase 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Glynase 5 Tablet safe for pregnant women?
Glynase can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Glynase 5 Tablet safe during breastfeeding?
Glynase should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Glynase 5 Tablet on the Kidneys?
Use of Glynase may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Glynase 5 Tablet on the Liver?
Use of Glynase may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Glynase 5 Tablet on the Heart?
Glynase may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Glynase 5 Tablet unless your doctor advises you to do so -
Is this Glynase 5 Tablet habit forming or addictive?
Forming a habit of Glynase 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Glynase 5 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Glynase 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Glynase 5 Tablet for mental disorders.
Interaction between Food and Glynase 5 Tablet
There is no information on the effects of taking Glynase 5 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glynase 5 Tablet
Consumption of alcohol and Glynase 5 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucotrol - glipizide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158